Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Serina Therapeutics, Inc. (SER) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.13M |
|
$-6.45M |
|
-- |
|
$0.13M |
|
$5.70M |
|
$-5.57M |
|
$-0.90M |
|
$-6.46M |
|
$-6.46M |
|
$-6.46M |
|
$-6.46M |
|
$-6.46M |
|
$-6.46M |
|
$-5.57M |
|
$-5.55M |
|
10.00M |
|
10.00M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$7.99M |
|
$0.59M |
|
$0.95M |
|
$8.94M |
|
$3.56M |
|
-- |
|
$3.73M |
|
$7.29M |
|
$-3.29M |
|
$1.65M |
|
$1.65M |
|
10.14M |
|
| Cash Flow Statement Financials | |
$-8.07M |
|
$-0.05M |
|
$10.49M |
|
$3.67M |
|
$6.04M |
|
$2.37M |
|
$1.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-4280.77% |
|
-4280.77% |
|
-- |
|
-4970.77% |
|
-4960.00% |
|
$-8.12M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
196.17% |
|
-392.59% |
|
-72.27% |
|
-392.59% |
|
$0.16 |
|
$-0.81 |
|
$-0.81 |
|